Hematology/oncology Pharmacy Association
trade association
Based in IL
AI Overview
With $300K in lobbying spend across 8 quarterly filings, Hematology/oncology Pharmacy Association is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2019 to 2021.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2019 | $80K |
| 2020 | $170K |
| 2021 | $50K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Hematology/oncology Pharmacy Association disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Budget/Appropriations
Drug price monitoring; H.R. 1730, S. 741 The Cancer Drug Parity Act; H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act
Drug price monitoring; H.R. 1730, S. 741 The Cancer Drug Parity Act; H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act; S. 3548 the Coronavirus Aid, Relief, and Economic Security Act (CARES Act)
FY 2021 Labor, Health and Human Services, Education, and Related Agencies.
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.